| Gastric cancer: a comprehensive review of current and future treatment strategies | 2020/09/07 | English | 302 |
| The tyrosine phosphatase Shp2 (PTPN11) in cancer | 2008/02/20 | English | 293 |
| Hypoxia-driven selection of the metastatic phenotype | 2007/04/26 | English | 292 |
| The pre-metastatic niche: finding common ground | 2013/05/01 | English | 292 |
| Novel functions of TIMPs in cell signaling | 2006/03/01 | English | 290 |
| Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment | 2007/04/14 | English | 290 |
| Progression and metastasis of lung cancer | 2016/03/01 | English | 289 |
| HER2 expression status in diverse cancers: review of results from 37,992 patients | 2015/02/25 | English | 272 |
| Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer | 2009/12/01 | English | 270 |
| Metastasis of squamous cell carcinoma of the oral tongue | 2007/09/03 | English | 269 |
| Discoidin domain receptor tyrosine kinases: new players in cancer progression | 2012/02/26 | English | 267 |
| ABCG2: determining its relevance in clinical drug resistance | 2007/02/24 | English | 265 |
| Hypoxia, inflammation, and the tumor microenvironment in metastatic disease | 2010/04/15 | English | 264 |
| PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment | 2016/11/28 | English | 258 |
| The folate receptor: What does it promise in tissue-targeted therapeutics? | 2007/02/27 | English | 251 |
| Immune cells as mediators of solid tumor metastasis | 2007/12/08 | English | 250 |
| Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer | 2012/06/23 | English | 240 |
| Cyclooxygenases, prostanoids, and tumor progression | 2007/09/01 | English | 240 |
| Molecular basis of antifolate resistance | 2007/02/27 | English | 239 |
| Osteopontin: regulation in tumor metastasis | 2007/11/30 | English | 234 |
| Bone marrow-derived mesenchymal stem cells and the tumor microenvironment | 2010/04/22 | English | 233 |
| Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring | 2015/02/27 | English | 231 |
| The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond | 2019/05/10 | English | 226 |
| Bone marrow cells in the ‘pre-metastatic niche’: within bone and beyond | 2006/12/22 | English | 225 |
| Bee venom in cancer therapy | 2011/11/23 | English | 224 |
| Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy | 2011/01/20 | English | 224 |
| The other side of MMPs: Protective roles in tumor progression | 2007/08/24 | English | 223 |
| The Met tyrosine kinase receptor in development and cancer | 2008/01/04 | English | 223 |
| Normal platelet function | 2017/06/01 | English | 220 |
| Tumor detection using folate receptor-targeted imaging agents | 2008/06/04 | English | 216 |